Treatment Registry

Molecule

Dulaglutide

Approved product exists

An FDA-approved dulaglutide product exists. The register holds 5 recorded programs, 0 with a comparable monthly price, across 1 category of dulaglutide. Classification recorded October 2026. FDA source.

Trulicity (dulaglutide) is indicated for type 2 diabetes and is not a weight-loss drug. An approved dulaglutide product does not establish weight-loss approval or which product, form or indication a provider offers. Indication source.

Forms

  • Dulaglutide · formulation not established5 entries

Programs with formulation not established

More columns to the right? Scroll across the table to see all details.

EntryProviderFormRecorded price
with its payment basis
Last verifiedLink
EntryTR-1122Provider9amHealthFormNot recordedRecorded priceNo comparable monthly priceLast verifiedOctober 2026Record
EntryTR-1069ProviderJRNYSFormNot recordedRecorded priceNo comparable monthly priceLast verifiedOctober 2026Record
EntryTR-1094ProviderJumpstartMDFormNot recordedRecorded priceNo comparable monthly priceLast verifiedOctober 2026Record
EntryTR-1127ProviderKlarity HealthFormInjection, penRecorded priceNo comparable monthly priceLast verifiedOctober 2026Record
EntryTR-1136Not verifiedProviderKlinicFormInjection, penRecorded priceNo comparable monthly priceLast verifiedOctober 2026Record

A compounded preparation is not itself an FDA-approved product, so each form is recorded and priced separately rather than rolled together.